Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.

GDOT posts strong Q2 results with EPS up 60% and revenues surging 23.1%, led by robust B2B Services growth.

Aquestive Therapeutics, Inc. (NASDAQ:AQST ) Q2 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants A. Ernest Toth - Chief Financial Officer Carl N.

Key Points in This Article: Berkshire Hathaway's (BRK-A)(BRK-B)stock has underperformed the S&P 500 by 25% since Buffett's departure announcement.

Oklo (NYSE:OKLO) provided investors an update on its strategic progress along with its Q2 financial results, targeting commercial operations between 2027 and early 2028. The pre-revenue nuclear energy company reported a net loss of $28 million for the quarter.

Puma Biotech (PBYI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Xeris Biopharma (XERS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate Watts Water's (WTS) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Explore how MKS' (MKSI) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Explore Lam Research's (LRCX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants B. John Lindeman - CEO & Director Kevin Patrick O'Brien - Chief Financial Officer Conference Call Participants Dmitry Silversteyn - Water Tower Research LLC John Di Domenico - Unidentified Company Operator Good day, ladies and gentlemen, and thank you for standing by.

Specialty grocer expands its reach in vitamin and supplement marketplace Specialty grocer expands its reach in vitamin and supplement marketplace

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP ) Q2 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants David P. Luci - Co-Founder, President, CEO, Corporate Secretary & Director Robert G.

PAAS, CSL and DHT announce fresh dividend hikes, offering steady income streams amid renewed market volatility.

TTD stock slides post Q2 as macro headwinds and competition remain concerns, but CTV growth and Kokai adoption offer bright spots.

GPRO tops Q2 revenue forecasts despite sales drop, aiming for growth rebound with upcoming hardware and software launches.

SAN DIEGO , Aug. 12, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Red Cat Holdings, Inc. (NASDAQ: RCAT). Investors who purchased shares of Red Cat Holdings, Inc. (NASDAQ: RCAT) prior to March 2022 and continue to hold any of those NASDAQ: RCAT shares, also have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

Although Tesla (NASDAQ: TSLA) stock is on an impressive five-day winning streak, the equity could face more pressure after Guggenheim analyst Ronald Jewsikow reaffirmed a ‘Sell' rating.

AEM's ultra-low debt, surging free cash flow and strong gold prices boost its growth potential and shareholder returns.

AllianceBernstein, Interactive Brokers and Janus Henderson shine as financials surge on Fed policy tailwinds in 2025.